Neurocrine Biosciences
NBIX
#1471
Rank
A$21.01 B
Marketcap
A$206.72
Share price
-0.66%
Change (1 day)
-4.72%
Change (1 year)
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

We have found no stock splits for this company